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Atherosclerotic plaque tends to form in areas of
low shear stress.1 Areas of low shear stress may have
flow stagnation leading to longer contact time
between lipids and the arterial wall, platelet adhesion,
and hypoxia. Drag reducing polymers (DRPs) are a
distinct class of chemical compounds that can reduce
the frictional resistance to flow in pipes by as much as
75% under conditions of turbulent flow.2 DRPs are
characterized by extraordinarily high molecular
weights (greater than 106) or the ability to form mol-
ecular aggregates.2 Several studies have indicated that
DRPs decrease atherosclerotic plaque formation.3,4
Although these studies have demonstrated an effec-
tive inhibition of plaque formation, their specific
mechanism of action remains unknown. 
This study was conducted to determine whether
DRPs elevate shear forces in arterial regions charac-
terized by normally low shear stress. The results pro-
vide insight into the potential mechanisms for the
antiatherogenic properties of DRPs. Understanding
how DRPs decrease atherosclerotic plaque forma-
tion may aid in the development of more practical
medications with similar effects.
MATERIAL AND METHODS
The DRP used in this study was a polyethylene
oxide with an approximate molecular weight of 14 ×
106 (Polyox WSR 301, NF grade; Union Carbide,
Danbury, Conn). The polymer was prepared in a
manner similar to the method recommended by the
manufacturer. A mechanical stirrer (model 700-
4510) with a turbine propeller (no. 4544-10;
Barnant Co, Barrington, Ill) was used to create a
vortex in 100 mL phosphate-buffered saline in a
500-mL beaker into which 0.50 g DRP was sprin-
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kled. The solution was then transferred to a 1-L
polypropylene bottle and placed on a laboratory
rocker (Buchler Instruments, Fort Lee, NJ) for 16
to 20 hours.
Six adult mongrel dogs underwent laparotomy
under sterile conditions using pentobarbital anesthe-
sia. Heart rate and blood pressure were monitored
during the experiment. Shear rate measurements
were not taken during any brief, temporary changes
in these physiologic measurements. Proximal and
distal control of the infrarenal aorta was obtained,
and a 50% stenosis was created in the left half of the
aorta using a 5-0 Prolene suture (Fig 1). Previous
studies in our laboratory demonstrated that within a
few aortic diameters of the stenosis, the left half of
the aorta in this model is a region with low shear
stress that tends to develop atherosclerotic plaque in
animal models prone to develop atherosclerosis,
whereas the right half of the aorta is a region with
high shear stress that tends to resist the development
of atherosclerotic plaque.1
A Doppler ultrasound probe mounted at 45
degrees on a micromanipulator with vernier calibra-
tion was used to record flow velocities at six 4-mm
intervals along the right and left lateral walls of the
aorta. The probe was connected to a specially mod-
ified 20-MHz Crystal Biotech VF-1 Pulsed Doppler
System with vernier calibration. Before administer-
ing the DRP, flow velocity profiles were evaluated at
0.1-mm depths moving into the lumen starting at
the inner aortic wall. The Doppler signals were dig-
itized using a DATAQ CODAS analog to digital
converter and were then stored digitally in an HP
Vectra computer. Linear regression of these velocity
profiles (dv/drr=0) was used to numerically calculate
the maximum shear rates along the aortic wall.1
The DRP solution was then administered to the
dogs for 30 minutes at a rate of 0.16 mg/kg/min
using a syringe pump (model 22; Harvard Apparatus,
South Natick, Mass). Flow velocity profiles were
determined at the same locations after the adminis-
tration of DRP, and linear regression was again used
to calculate the maximum shear rates from these val-
ues. The blood viscosity was measured before and
after the DRP infusion on a dynamic viscosimeter.5
The maximum shear rates at these locations were
compared before and after the administration of
DRP using the paired t test.
RESULTS
Blood viscosity was measured to be 0.040 poise
for this range of shear rates as measured on a dynam-
ic viscosimeter both before and after infusions of the
amount of DRP used in this study, which is consis-
tent with previous experimental results.1,6 Although
there were minor fluctuations, heart rate and blood
pressure did not vary in any systematic manner dur-
ing the relatively short interval needed for these
measurements.
The maximum shear rate occurring during the
cardiac cycle on the side of the aortic stenosis (plica-
tion) was 9.96 ± 1.52/sec before the administration
of the DRP and 14.27 ± 2.01/sec after the adminis-
tration of the DRP (P = .0240). The maximum shear
rate on the side of the unstenosed aortic wall was
57.25 ± 7.93/sec before the administration of the
DRP and 44.80 ± 6.23/sec after the administration
of the DRP (P = .0081). The above variances are
listed as standard error of the mean.
DISCUSSION
DRPs have been shown to suppress the develop-
ment of atherosclerosis in hyperlipidemic rabbits and
guinea pigs.3,4 Although DRPs have many hemody-
Fig 1. Line drawing of the experimental setup showing
the dog aortoiliac arteries, renal arteries, suture line across
the left half of the aorta, and sites of ultrasound probe
placement. Dashed lines represent artist’s rendition of the
blood flow.
namic effects and may have some pharmacologic
effects, the mechanism by which they inhibit the
development of atherosclerosis has not been fully
elucidated. The previous studies by Faruqui et al3
and Ertepinar et al4 examined the histopathology of
the arterial wall and evaluated morphometric data
but did not evaluate whether alterations in blood
flow hemodynamics might be the mechanism where-
by DRPs inhibit the development of atherosclerosis.
Several studies have demonstrated that low shear
stress is associated with atherosclerotic plaque forma-
tion.1,7,8 Areas of low wall shear stress have flow stag-
nation resulting in increased contact time between
intravascular lipids and the arterial wall.9 Low shear
stress and flow stagnation also lead to platelet adhe-
sion and localized hypoxia.
DRPs have been shown to increase blood flow
and decrease turbulence.4,10 These polymers have
some of their most significant effects under condi-
tions of oscillatory,11 pulsatile,12 and helical13 blood
flow. The currently accepted fluid mechanical expla-
nation for this decrease in turbulence is that linear,
long chain polymers may align themselves parallel to
the axis of flow and help stabilize or laminate fluid
flow. The ability of these polymers to stabilize or
laminate fluid flow may increase shear stress in areas
of blood flow with low shear. DRPs may also
increase viscosity,14 although it did not do so with
the amounts infused during this experiment. 
This study investigated whether DRPs increase
shear stress in areas normally exposed to low shear.
Because increasing shear stress in these regions of
low shear is known to inhibit the development of
atherosclerosis, the effect of DRPs on shear stress
may provide a possible explanation for their inhibi-
tion of atherosclerotic plaque formation.
Our previous studies have demonstrated that
increasing the mean and maximum shear stress along
the arterial wall in areas normally exposed to low
shear decreases the development of atherosclerotic
plaque formation.1 This present study demonstrates
that DRPs significantly increase the maximum shear
stress along the arterial wall in areas normally
exposed to low shear. Although the shear rate on the
unstenosed side of the aortic wall was decreased by
the effects of the DRP, this shear rate was still 4.5
times the shear rate on the stenosed aortic wall before
the administration of the DRP. This study implies
that at least part of the ability of DRPs to inhibit ath-
erosclerotic plaque formation is due to their ability to
increase arterial wall shear stress in areas normally
exposed to low shear. The development of pharma-
ceutical agents that modify shear stress and mimic the
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effects of DRPs may provide a mechanism to clinical-
ly inhibit the development of atherosclerosis.
We chose to use linear regression rather than
polynomial regression to estimate shear rates. If the
data precisely fit a specific polynomial regression, it
may be beneficial to use a higher-order polynomial
regression. However, given the poor numeric prop-
erties of higher-order polynomials, a polynomial
order any higher than necessary should not be cho-
sen. Higher-order polynomials can be differentiated
more times before they become zero, and wavelike
ripples can be formed that significantly alter the
waveform slope.15
Shear stress is known to affect the distribution of
atherosclerosis,16 arterial caliber,17 and poststenotic
dilatation.18 Zarins et al16 demonstrated that in the
carotid bulb, areas of low shear and plaque forma-
tion were also associated with flow separation, rever-
sal of axial flow, and the development of counter-
rotating helical trajectories. Further studies of the
effects of DRP could investigate whether DRPs
affect flow patterns, as well as shear stress.
Zarins et al17 demonstrated that areas of increased
shear stress develop compensatory dilatation of the
arterial lumen. Ojha et al18 showed that poststenotic
arterial dilatation occurred in areas of maximum shear
stress fluctuations between positive and negative val-
ues. Although DRP increases shear stress in areas nor-
mally exposed to low shear stress, its effects on arter-
ial diameter were not investigated in this study.
Previous studies in our laboratory5 have indicated that
DRPs may increase blood flow through stenotic ves-
sels without altering flow in normal vessels. Further
studies are needed to determine the long-term effects
of DRP on arterial diameter.
REFERENCES
1. Sawchuk AP, Unthank JL, Davis TE, Dalsing MC. A
prospective in-vivo study of the relationship between blood
flow hemodynamics and atherosclerosis in a hyperlipidemic
swine model. J Vasc Surg 1994;19:58-64.
2. Morgan SE, McCormick CL. Water-soluble copolymers
XXXII: macromolecular drag reduction—a review of predic-
tive theories and the effects of polymer structure. Prog
Polymer Sci 1990;15:507-49.
3. Faruqui FI, Otten MD, Polimeni PI. Protection against
atherogenesis with the polymer drag-reducing agent Separan
AP-30. Circulation 1987;75:3,627-35.
4. Ertepinar H, Suzen B, Ozoran Y, Ceylan S, Yeginoglu G,
Uremek G. Effects of drag reducing polymer on atheroscle-
rosis. Biorheology 1990;27:5,631-44.
5. Unthank JL, Lalka SG, Nixon JC, Sawchuk AP. Improvement
of flow through arterial stenoses by drag reducing agents. J
Surg Res 1992;53:625-30.
6. Greene HL, Nokes RF, Thomas LC. Biomedical implications
of drag reducing agents. Biorheology 1971;7:221-2.
JOURNAL OF VASCULAR SURGERY
764 Sawchuk, Unthank, and Dalsing October 1999
7. Friedman MH, Bargeron CD, Deters OJ, Hutchins GM, Mark
FF. Correlation between wall shear and intimal thickness at a
coronary artery branch. Atherosclerosis 1987;68:27-33.
8. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon
RF, Glagov S. Carotid bifurcation atherosclerosis: quantita-
tive correlation of plaque localization with flow velocity pro-
files and wall shear stress. Circ Res 1983;53:502-14.
9. Caro CG. Arterial fluid mechanics and atherogenesis. Clin
Hemorheol 1982;2:131-6.
10. Mostardi RA, Greene HL, Nokes RF, Thomas LC, Lue T.
The effect of drag reducing agents on stenotic flow distur-
bances in dogs. Biorheology 1976;13:137-41.
11. Voitkounsky YI, Amfilokhiev WR, Pavlofsky VA. Paper dis-
tributed on occasion of the ONR 9th symposium on Naval
Hydrodynamics, Paris (1972).
12. Driels MR, Ayyash S. Drag reduction in laminar flow. Nature
1976;259:389-90.
13. Kuo JT, Kovasznay LSG. Drag reducing polymer in heli-
coidal flow. J Fluid Engineer 1981;103:491-6.
14. Polimeni PI, Ottenbreit B, Coleman P. Enhancement of aor-
tic blood flow with a linear anionic macropolymer of extraor-
dinary molecular length. J Mol Cell Cardiol 1985;17:721-4.
15. Hanselman D, Littlefield L. Matlab version 5 users guide.
Saddle River (NJ): Prentice Hall; 1997. p. 156.
16. Zarins CK, Giddens DP, Bharadvaj BK, et al. Carotid bifur-
cation atherosclerosis. Quantitative correlation of plaque
localization with flow velocity profiles and wall shear stress.
Circ Res 1983;53:502-14.
17. Zarins CK, Zatina MA, Giddens DP, et al. Shear stress regu-
lation of artery lumen diameter in experimental atherogene-
sis. J Vasc Surg 1987;5:413-20.
18. Ojha M, Johnston KW, Cobbold RS. Evidence of a possible
link between poststenotic dilation and wall shear stress. 
J Vasc Surg 1990;11:127-33.
Submitted Feb 17, 1999; accepted May 26, 1999.
